BIOSSÍNTESE E AÇÃO DOS EICOSANOIDES NO PROCESSO INFLAMATÓRIO
DOI:
https://doi.org/10.66104/npraft23Palabras clave:
Prostaglandins; Metabolism; Lipids; Inflammation; Health.Resumen
Eicosanoids are hormones derived from polyunsaturated fatty acids, and are responsible for regulating the immune response, especially in the inflammatory process and in autoimmune diseases. Such substances may have a highly inflammatory nature, and are triggered by their level of concentration in the body, which leads to the development of cardiovascular diseases, cancer, neuroinflammation and anaphylaxis. Enzymes that are part of the metabolic process are the main targets of anti-inflammatory drugs. The present research aimed to investigate the metabolism of the main eicosanoids that act on the inflammatory response and characterize the polyunsaturated fatty acids that constitute the profile of these hormones. This study addresses the current understanding of the metabolism of eicosanoids and may contribute to the discovery of new biopharmaceuticals and consolidation of the knowledge on the pathophysiological process of inflammatory diseases.
Descargas
Referencias
ALVAREZ, M. L.; LORENZETTI, F. Role of eicosanoids in liver repair, regeneration and cancer. Biochemical Pharmacology, v. 192, art. 114732, 2021. Disponível em: https://doi.org/10.1016/j.bcp.2021.114732. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bcp.2021.114732
ABDELLATIF, K. R. A.; ABDELALL, E. K. A.; ELSHEMY, H. A. H.; PHILOPPES, J. N.; HASSANEIN, E. H. M.; KAHK, N. M. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates. Bioorganic Chemistry, v. 114, art. 105122, 2021. Disponível em: https://doi.org/10.1016/j.bioorg.2021.105122. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bioorg.2021.105122
AMIN, N. H.; HAMED, M. I. A.; ABDEL-FATTAH, M. M.; ABUSABAA, A. H. A.; EL-SAADI, M. T. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects. Bioorganic Chemistry, v. 116, art. 105394, 2021. Disponível em: https://doi.org/10.1016/j.bioorg.2021.105394. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bioorg.2021.105394
ASHTON, A. W.; ZHANG, Y.; CAZZOLLI, R.; HONN, K. V. The role and regulation of Thromboxane A2 signaling in cancer – trojan horses and misdirection. Molecules, v. 27, art. 6234, 2022. Disponível em: https://doi.org/10.3390/molecules27196234. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/molecules27196234
BAI, H.; YANG, C.; PAN, W.; SHUN, R.; ZHU, B. T. Inhibition of cyclooxygenase by blocking the reducing cosubstrate at the peroxidase site. European Journal of Pharmacology, v. 899, art. 174036, 2021. Disponível em: https://doi.org/10.1016/j.ejphar.2021.174036. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.ejphar.2021.174036
BADIMON, L.; VILAHUR, G.; ROCCA, B.; PATRONO, C. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Cardiovascular Research, v. 117, p. 2001, 2021. Disponível em: https://doi.org/10.1093/cvr/cvab003. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1093/cvr/cvab003
BIRINGER, R. G. A review of prostanoid receptors: Expression, characterization, regulation, and mechanism of action. Journal of Cell Communication and Signaling, v. 15, p. 155, 2021. Disponível em: https://doi.org/10.1007/s12079-020-00585-0. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1007/s12079-020-00585-0
BRAUNE, S.; KÜPPER, J.; JUNG, F. Effect of prostanoids on human platelet function: An overview. International Journal of Molecular Sciences, v. 21, art. 9020, 2020. Disponível em: https://doi.org/10.3390/ijms21239020. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/ijms21239020
BHATIA, P.; SINGH, N. Thromboxane A2 synthase inhibition ameliorates endothelial dysfunction, memory deficits, oxidative stress and neuroinflammation. Physiology & Behavior, v. 241, art. 113592, 2021. Disponível em: https://doi.org/10.1016/j.physbeh.2021.113592. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.physbeh.2021.113592
CANZI, E. F.; LOPES, R. B.; ROBELDO, T.; BORRA, R.; SILVA, M. F. G. F.; OLIVEIRA, R. V.; MAIA, Q. B. C. Prostaglandins E2 and F2α levels in human menstrual fluid. Journal of Chromatography B, v. 1109, p. 60-66, 2019. Disponível em: https://doi.org/10.1016/j.jchromb.2019.01.025. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.jchromb.2019.01.025
CEBULLA, D.; GEFFEN, C. V.; KOLAHIAN, S. The role of PGE2 and EP receptors on lung immune and structural cells. Pharmacology & Therapeutics, v. 241, art. 108313, 2023. Disponível em: https://doi.org/10.1016/j.pharmthera.2022.108313. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.pharmthera.2022.108313
CIVELEK, E.; OZEN, G. The biological actions of prostanoids in adipose tissue. Prostaglandins, Leukotrienes and Essential Fatty Acids, v. 186, art. 102508, 2022. Disponível em: https://doi.org/10.1016/j.plefa.2022.102508. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.plefa.2022.102508
COLLU, R.; POST, J. M.; SCHERMA, M.; GIUNTI, E.; FRATTA, W.; LUTZ, B.; FADDA, P.; BINDILA, L. Altered brain levels of arachidonic acid-derived inflammatory eicosanoids. Biochimica et Biophysica Acta, v. 1865, art. 158578, 2020. Disponível em: https://doi.org/10.1016/j.bbalip.2019.158578. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bbalip.2019.158578
CUI, J.; SHAN, K.; YANG, Q.; CHEN, W.; FENG, N.; CHEN, Y. Q. Eicosanoid production by macrophages during inflammation depends on the M1/M2 phenotype. Prostaglandins & Other Lipid Mediators, v. 160, art. 106635, 2022. Disponível em: https://doi.org/10.1016/j.prostaglandins.2022.106635. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.prostaglandins.2022.106635
DAS, U. N. Bioactive lipids in COVID-19: Further evidence. Archives of Medical Research, v. 52, p. 107-120, 2021. Disponível em: https://doi.org/10.1016/j.arcmed.2020.09.006. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.arcmed.2020.09.006
DOMINGO, C.; PALOMARES, S.; SANDHAM, D. A.; ERPENBECK, V.; ALMAN, P. The prostaglandin D2 receptor 2 pathway in asthma. Respiratory Research, v. 19, p. 1-8, 2018. Disponível em: https://doi.org/10.1186/s12931-018-0893-x. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1186/s12931-018-0893-x
ERTAŞ, M.; BILTEKIN, S. N.; BERK, B.; YURTTAŞ, L.; DEMIRAYAK, S. Synthesis of triazine derivatives and COX inhibitory activity. Phosphorus, Sulfur, and Silicon, v. 197, p. 1123, 2022. Disponível em: https://doi.org/10.1080/10426507.2022.2062756. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1080/10426507.2022.2062756
EMON, N. U.; ALAM, S.; RUDRA, S.; AL HAIDAR, I. K.; FARHAD, M.; RANA, M. E. H.; GANGULY, A. Antipyretic activity of Caesalpinia digyna leaves extract. Saudi Journal of Biological Sciences, v. 28, p. 5302-5309, 2021. Disponível em: https://doi.org/10.1016/j.sjbs.2021.05.050. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.sjbs.2021.05.050
FAGGIANO, A.; MAZZILLI, R.; NATALICCHIO, A.; et al. Corticosteroids in oncology. Critical Reviews in Oncology/Hematology, v. 180, art. 103826, 2022. Disponível em: https://doi.org/10.1016/j.critrevonc.2022.103826. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.critrevonc.2022.103826
FINETTI, F.; TRAVELLI, C.; ERCOLI, J.; COLOMBO, G.; BUOSO, E.; TRABALZINI, L. Prostaglandin E2 and cancer. Biology, v. 9, n. 12, art. 434, 2020. Disponível em: https://doi.org/10.3390/biology9120434. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/biology9120434
FONTÁNYI, Z.; SZIVA, E. R.; PÁL, E.; HADJADJ, L.; MONORI-KISS, A.; HORVÁTH, E. M.; BENKO, R.; MAGYAR, A.; HEINZLMANN, A.; BENYÓ, Z.; NÁDASY, G. L.; MASSZI, G.; VÁRBÍRÓ, S. Vitamin D deficiency reduces vascular reactivity of coronary arterioles in male rats. Current Issues in Molecular Biology, v. 43, p. 79, 2021. Disponível em: https://doi.org/10.3390/cimb43010007. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/cimb43010007
GAO, L.; SHI, H.; SHERCHAN, P.; TANG, H.; PENG, L.; XIE, S.; LIU, R.; HU, X.; TANG, J.; XIA, Y.; ZHANG, J. H. Inhibition of lysophosphatidic acid receptor 1 attenuates neuroinflammation via PGE2/EP2/NOX2 signalling. Brain, Behavior, and Immunity, v. 91, p. 615-626, 2021. Disponível em: https://doi.org/10.1016/j.bbi.2020.09.032. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bbi.2020.09.032
GARTNER, S.; ROCA-FERRER, J.; FERNANDEZ-ALVAREZ, P.; LIMA, I.; ROVIRA-AMIGO, S.; GARCÍA-ARUMI, E.; TIZZANO, E. F.; PICADO, C. Elevated prostaglandin E2 synthesis in cystic fibrosis. Journal of Clinical Medicine, v. 13, art. 2050, 2024. Disponível em: https://doi.org/10.3390/jcm13072050. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/jcm13072050
GRYCMACHER, K.; BORUSZEWSKA, D.; SINDEREWICZ, E.; KOWALCZYK-ZIEBA, I.; STAŻKIEWICZ-CHODOR, J.; WOCŁAWEK-POTOCKA, I. Prostaglandin F2α production possibility and its receptors expression in bovine embryos. BMC Veterinary Research, v. 15, p. 1-15, 2019. Disponível em: https://doi.org/10.1186/s12917-019-1939-0. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1186/s12917-019-1939-0
HENDAWY, O. M.; GOMAA, H. A. M.; ALZAREA, S.; ALSHAMMARI, M. S.; MOHAMED, F. A. M.; MOSTAFA, Y. A.; ABDELAZEEM, A. H.; ABDELRAHMAN, M. H.; TREMBLEAU, L.; YOUSIF, B. G. M. Novel diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors. Bioorganic Chemistry, v. 116, art. 105302, 2021. Disponível em: https://doi.org/10.1016/j.bioorg.2021.105302. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bioorg.2021.105302
HU, J.; YANG, Z.; CHEN, X.; KUANG, S.; LIAN, Z.; KE, G.; LIAO, R.; MA, J.; LI, S.; ZHANG, L.; ZHUO, L.; FENG, Z.; LIANG, H.; LIN, T.; DONG, W.; LI, R.; LI, Z.; CHEN, Y.; LIANG, X.; SHI, W.; LIU, S. Thromboxane A2 is involved in hypertension in chronic kidney disease rats. European Journal of Pharmacology, v. 909, art. 174435, 2021. Disponível em: https://doi.org/10.1016/j.ejphar.2021.174435. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.ejphar.2021.174435
JU, Z.; LI, M.; XU, J.; HOWELL, D. C.; LI, Z.; CHEN, F. Recent development on COX-2 inhibitors as anti-inflammatory agents. Acta Pharmaceutica Sinica B, v. 12, p. 2807, 2022. Disponível em: https://doi.org/10.1016/j.apsb.2022.01.002. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.apsb.2022.01.002
KALKMAN, H. O.; HERSBERGER, M.; WALITZA, S.; BERGER, G. E. Molecular mechanisms of the antidepressant activity of omega-3 fatty acids. International Journal of Molecular Sciences, v. 22, art. 4393, 2021. Disponível em: https://doi.org/10.3390/ijms22094393. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/ijms22094393
KITAGAWA, K.; HAMAGUCHI, A.; FUKUSHIMA, K.; NAKANO, Y.; REGAN, W. R.; MASHIMO, M.; FUJINO, H. Down-regulation of COX-2 and PGE2 by interleukin-4. European Journal of Pharmacology, v. 920, art. 174863, 2022. Disponível em: https://doi.org/10.1016/j.ejphar.2022.174863. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.ejphar.2022.174863
KOEBERLE, A.; WERZ, O. Natural products as inhibitors of prostaglandin E2 and 5-lipoxygenase biosynthesis. Biotechnology Advances, v. 36, p. 1709-1723, 2018. Disponível em: https://doi.org/10.1016/j.biotechadv.2018.02.010. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.biotechadv.2018.02.010
KLOSKAR, A.; MALINOWSKA, M.; GABI-CIMINSKA, M.; JAKÓBKIEWICZ-BANECKA, J. Lipids and lipid mediators in ischemic stroke. International Journal of Molecular Sciences, v. 21, art. 3618, 2020. Disponível em: https://doi.org/10.3390/ijms21103618. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/ijms21103618
KRATZ, D.; WILKEN-SHMITZ, A.; SENS, A.; HAHNEFELD, A.; SCHOLICH, K.; GEISSLINGER, G.; GURKE, R.; THOMAS, D. Post-mortem changes of prostanoid concentrations in tissues of mice. Prostaglandins & Other Lipid Mediators, v. 162, art. 106660, 2022. Disponível em: https://doi.org/10.1016/j.prostaglandins.2022.106660. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.prostaglandins.2022.106660
KRÜGER-GENGE, A.; SCHULZ, C.; KRATZ, K.; LENDLEIN, A.; JUNG, F. Comparison of substrate materials in endothelialization studies. Clinical Hemorheology and Microcirculation, v. 69, p. 437-445, 2018. Disponível em: https://doi.org/10.3233/CH-189904. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3233/CH-189904
KHANNA, S.; CHICHESTER, K.; DEVINE, K.; GAO, P.; SAINI, S.; OLIVER, E. Increased local production of PGD2 in skin lesions. Journal of Allergy and Clinical Immunology, v. 149, p. 221, 2022. Disponível em: https://doi.org/10.1016/j.jaci.2021.12.722. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.jaci.2021.12.722
LEE, K.; LEE, S. H.; KIM, T. H. Biology of prostaglandins and their role in allergic airway disease therapy. International Journal of Molecular Sciences, v. 21, art. 1851, 2020. Disponível em: https://doi.org/10.3390/ijms21051851. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/ijms21051851
LITWACK, G. Hormones. 4. ed. United Kingdom: Academic Press, 2022. p. 474.
LIU, T. C.; CHIANG, C. F.; HO, C. T.; CHAN, J. P. Effect of GnRH on ovulatory response in dairy cows. Theriogenology, v. 105, p. 45-50, 2018. Disponível em: https://doi.org/10.1016/j.theriogenology.2017.09.013. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.theriogenology.2017.09.013
LOPES, A. J. O.; VASCONCELOS, C. C.; PEREIRA, F. A. N.; SILVA, R. H. M.; QUEIROZ, P. F. S.; FERNANDES, C. V.; GARCIA, J. B. S.; RAMOS, R. M.; ROCHA, C. Q.; LIMA, S. T. J. R. M.; CARTÁGENES, M. S. S.; RIBEIRO, M. N. S. Anti-inflammatory and antinociceptive activity of pollen extract. International Journal of Molecular Sciences, v. 20, art. 4512, 2019. Disponível em: https://doi.org/10.3390/ijms20184512. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/ijms20184512
LUCAS, G. N. C.; LEITÃO, A. C. C.; ALENCAR, R. L.; XAVIER, R. M. F.; DAHER, E. F.; SILVA, G. B. Pathophysiological aspects of nephropathy caused by NSAIDs. Brazilian Journal of Nephrology, v. 41, p. 124-130, 2019. Disponível em: https://doi.org/10.1590/2175-8239-JBN-2018-0107. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1590/2175-8239-jbn-2018-0107
MARTÍNEZ-PALACIOS, C. A.; CONCHA-SANTOS, S.; TOLEDO-CUEVAS, E. M.; RÍOS-DURÁN, M. G.; MARTÍNEZ-CHÁVEZ, C. C.; NAVARRETE-RAMÍREZ, P.; RAGGI, L.; STRUSSMANN, C.; HUALDE, J. P.; DEMICHELI, M. A.; MADRIGAL, J. F. High levels of docosahexaenoic acid in silversides. Neotropical Ichthyology, v. 18, p. 11, 2020. Disponível em: https://doi.org/10.1590/1982-0224-2019-0089. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1590/1982-0224-2019-0089
MARONE, G.; GALDIERO, M. R.; PECORARO, A.; PUCINO, V.; CRISCUOLO, G.; TRIASSI, M.; VARRICCHI, G. Prostaglandin D2 receptor antagonists in allergic disorders. Expert Opinion on Investigational Drugs, v. 28, p. 73-84, 2019. Disponível em: https://doi.org/10.1080/13543784.2019.1555237. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1080/13543784.2019.1555237
MEREY, L. S. F.; PALHARES, D. B.; PORTO, K. R. A.; MULLER, K. T. C. Ácidos graxos polinsaturados no sangue de gestantes. Interações, v. 19, p. 845-853, 2018. Disponível em: https://doi.org/10.20435/inter.v19i4.1615. Acesso em 2 jul. 2025. DOI: https://doi.org/10.20435/inter.v19i4.1615
MIAO, L. H.; REMO, S. C.; ESPE, M.; PHILIP, A. J. P.; HAMRE, K.; FJELLDAL, P. G.; SKJAERVEN, K.; HOLEN, E.; VIKESA, V.; SISSENER, N. H. Dietary plant oil and eicosanoid metabolism of Atlantic salmon. Fish and Shellfish Immunology, v. 123, p. 194-206, 2022. Disponível em: https://doi.org/10.1016/j.fsi.2022.02.049. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.fsi.2022.02.049
MORO, M. G.; OLIVEIRA, M. D. S. O.; TEIXEIRA, S. A.; MUSCARÁ, M. N.; SPOLIDORIO, L. C.; HOLZHAUSEN, M. Effects of selective versus non-selective COX-2 inhibition. Brazilian Dental Journal, v. 30, p. 133-138, 2019. Disponível em: https://doi.org/10.1590/0103-6440201902241. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1590/0103-6440201902241
NAM, G. S.; LEE, K.; NAM, K. Morin hydrate inhibits platelet activation. European Journal of Pharmacology, v. 865, art. 172734, 2019. Disponível em: https://doi.org/10.1016/j.ejphar.2019.172734. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.ejphar.2019.172734
NASRY, W. H. S.; RODRIGUEZ-LECOMPTE, J. C.; MARTIN, C. K. Role of COX-2/PGE2 in oral squamous cell carcinoma. Cancers, v. 10, art. 348, 2018. Disponível em: https://doi.org/10.3390/cancers10100348. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/cancers10100348
NESARAGI, A. R.; KAMBLE, R. R.; DIXIT, S.; KODASI, B.; HOOLAGERI, S. R.; BAYANNAVAR, P. K.; DASAPPA, J. P.; VOOTLA, S.; JOSHI, S. D.; KUMBAR, V. M. Green synthesis of therapeutically active oxadiazoles. Bioorganic & Medicinal Chemistry Letters, v. 43, art. 128112, 2021. Disponível em: https://doi.org/10.1016/j.bmcl.2021.128112. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bmcl.2021.128112
PIROLA, L.; CIESIELSKI, O.; BALCERCZYK, A. Role of ketone bodies and ketogenic diet in endothelial dysfunction. Biochemical Pharmacology, v. 206, art. 115346, 2022. Disponível em: https://doi.org/10.1016/j.bcp.2022.115346. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bcp.2022.115346
PIPER, K.; GARELNABI, M. Eicosanoids and cardiometabolic health. Journal of Clinical and Translational Endocrinology, v. 19, art. 100216, 2020. Disponível em: https://doi.org/10.1016/j.jcte.2020.100216. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.jcte.2020.100216
PRABHA, B.; SINI, S.; PRIYADARSHINI, T. S.; SASIKUMAR, P.; GOPALAN, G.; JOSEPH, J. P.; JITHIN, M. M.; SIVAN, V. V.; JAYAMURTHY, P.; RADHAKRISHNAN, K. V. Anti-inflammatory effect of ellagic acid derivative. Natural Product Research, v. 35, p. 3156, 2019. Disponível em: https://doi.org/10.1080/14786419.2019.1690486. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1080/14786419.2019.1690486
RASGOTI, S.; WILLMES, D. M.; NASSIRI, M.; BABINA, M.; WORM, M. PGE2 deficiency predisposes to anaphylaxis. Journal of Allergy and Clinical Immunology, v. 146, p. 1387-1396, 2020. Disponível em: https://doi.org/10.1016/j.jaci.2020.03.046. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.jaci.2020.03.046
RAUT, S.; KUMAR, A. V.; DESHPANDE, S.; KHAMBATA, K.; BALASINOR, N. H. Sex hormones regulate lipid metabolism in Sertoli cells. Journal of Steroid Biochemistry and Molecular Biology, v. 211, art. 105898, 2021. Disponível em: https://doi.org/10.1016/j.jsbmb.2021.105898. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.jsbmb.2021.105898
RITTCHEN, S.; HEINEMANN, A. Therapeutic potential of hematopoietic prostaglandin D2 synthase. Cells, v. 8, art. 619, 2019. Disponível em: https://doi.org/10.3390/cells8060619. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/cells8060619
ROCHA, S.; AMARO, A.; FERREIRA-JÚNIOR, M. D.; PROENÇA, C.; SILVA, A. M. S.; COSTA, V. M.; OLIVEIRA, S.; FONSECA, D. A.; SILVA, S.; CORVO, M. L.; FREITAS, M.; MATAFOME, P.; FERNANDES, E. Melanoxetin attenuates oxidative stress in diabetes mellitus model. Pharmaceutics, v. 16, art. 261, 2024. Disponível em: https://doi.org/10.3390/pharmaceutics16020261. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/pharmaceutics16020261
RODRIGUES, A. S.; SILVA, M. A. A.; BRANDÃO, T. O.; NASCIMENTO, A. B.; BITTENCOURT, R. F.; CHALHOUB, M.; BITTENCOURT, T. C. B. S. C.; RIBEIRO FILHO, A. Eficácia da associação PGF2 alfa-eCG em vacas leiteiras. Pesquisa Veterinária Brasileira, v. 38, p. 1518-1527, 2018. Disponível em: https://doi.org/10.1590/1678-5150-PVB-5371. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1590/1678-5150-pvb-5371
SASAKI, Y.; KUWATA, H.; AKATSU, M.; YAMAKAWA, Y.; OCHIAI, T.; YODA, E.; NAKATANI, Y.; YOKOYAMA, C.; HARA, S. Involvement of prostacyclin synthase in obesity. Prostaglandins and Other Lipid Mediators, v. 153, art. 106523, 2021. Disponível em: https://doi.org/10.1016/j.prostaglandins.2020.106523. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.prostaglandins.2020.106523
SHEN, S.; GONG, C.; JIN, K.; ZHOU, L.; XIAO, Y.; MA, L. Omega-3 supplementation and coronary heart disease risks. Frontiers in Nutrition, v. 9, p. 1-14, 2022. Disponível em: https://doi.org/10.3389/fnut.2022.809311. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3389/fnut.2022.809311
SHEN, B. Q.; SANKARANARAYANAN, I.; PRINCE, T. J.; FERREIRA, D. T. Sex differences in prostaglandin signaling. Scientific Reports, v. 13, art. 4670, 2023. Disponível em: https://doi.org/10.1038/s41598-023-31603-x. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1038/s41598-023-31603-x
SHI, H.; SUN, X.; KONG, A.; MA, H.; XIE, Y.; CHENG, D.; KONG, C.; WONG, C.; ZHOU, Y.; GU, J. Cadmium induces epithelial–mesenchymal transition via PGE2. Ecotoxicology and Environmental Safety, v. 207, art. 111480, 2021. Disponível em: https://doi.org/10.1016/j.ecoenv.2020.111480. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.ecoenv.2020.111480
TANG, X.; HOU, Y.; SCHWARTZ, T. W.; HAEGGSTROM, J. Z. Metabolite G-protein coupled receptor signaling. Biochemical Pharmacology, v. 204, art. 115208, 2022. Disponível em: https://doi.org/10.1016/j.bcp.2022.115208. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bcp.2022.115208
UCHIDA, Y.; SOMA, T.; KAKAGOME, K.; KOBAYASHI, T.; NAGATA, M. Implications of prostaglandin D2 and leukotrienes in asthma. Annals of Allergy, Asthma & Immunology, v. 123, p. 88, 2019. Disponível em: https://doi.org/10.1016/j.anai.2019.04.008. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.anai.2019.04.008
WANG, M.; MA, L.; YANG, Y.; XIAO, Z.; WAN, J. N-3 fatty acids in alcoholic liver disease. Critical Reviews in Food Science and Nutrition, v. 59, p. 116-129, 2019. Disponível em: https://doi.org/10.1080/10408398.2018.1544542. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1080/10408398.2018.1544542
WAUTIER, J. L.; WAUTIER, M. P. Pro- and anti-inflammatory prostaglandins and cytokines in humans. International Journal of Molecular Sciences, v. 24, art. 9647, 2023. Disponível em: https://doi.org/10.3390/ijms24119647. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/ijms24119647
WONG, G. S.; REDES, J. L.; BALENGA, N.; MCCULLOUGH, M.; FUENTES, N.; GOKHALE, A.; WHITE-KOZIOL, C.; JUDE, J. A.; MADIGAN, L. A.; CHAN, E. C.; JESTER, W. H.; BIARDEL, S.; FLAMAND, N.; P.; R. A.; DRUEY, K. M. RGS4 promotes airway hyperresponsiveness by inhibiting PGE2 biosynthesis. Journal of Allergy and Clinical Immunology, v. 146, p. 1152-1164, 2020. Disponível em: https://doi.org/10.1016/j.jaci.2020.03.004. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.jaci.2020.03.004
WRÓBEL-BIEDRAWA, D.; PODOLAK, I. Anti-neuroinflammatory effects of adaptogens. Molecules, v. 29, art. 866, 2024. Disponível em: https://doi.org/10.3390/molecules29040866. Acesso em 2 jul. 2025. DOI: https://doi.org/10.3390/molecules29040866
XIA, F.; HE, C.; REN, M.; XU, F.; WAN, J. Quantitative profiling of eicosanoids in type 2 diabetes mellitus. Analytica Chimica Acta, v. 1120, p. 24-35, 2020. Disponível em: https://doi.org/10.1016/j.aca.2020.04.064. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.aca.2020.04.064
XIA, J.; WANG, S.; ZHANG, J. Anti-inflammatory and antioxidative effects of conbercept. Biochemical and Biophysical Research Communications, v. 508, p. 1264-1270, 2019. Disponível em: https://doi.org/10.1016/j.bbrc.2018.12.049. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.bbrc.2018.12.049
YU, L.; LIU, Q.; CANNING, B. J. Autocrine and paracrine regulation of allergen-induced mast cell mediator release. European Journal of Pharmacology, v. 822, p. 108-118, 2018. Disponível em: https://doi.org/10.1016/j.ejphar.2017.11.017. Acesso em 2 jul. 2025. DOI: https://doi.org/10.1016/j.ejphar.2017.11.017
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Valeska Regina Rodrigues da Cruz, José Antônio Alves Júnior, Francisco dos Santos Panero
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
